0000805928-21-000178.txt : 20211229
0000805928-21-000178.hdr.sgml : 20211229
20211229161529
ACCESSION NUMBER: 0000805928-21-000178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211227
FILED AS OF DATE: 20211229
DATE AS OF CHANGE: 20211229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Billet Isabelle
CENTRAL INDEX KEY: 0001756302
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36046
FILM NUMBER: 211529038
MAIL ADDRESS:
STREET 1: C/O AXOGEN, INC., 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axogen, Inc.
CENTRAL INDEX KEY: 0000805928
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411301878
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: (386) 462-6817
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
FORMER COMPANY:
FORMER CONFORMED NAME: AxoGen, Inc.
DATE OF NAME CHANGE: 20111004
FORMER COMPANY:
FORMER CONFORMED NAME: LECTEC CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
wf-form4_164081251560102.xml
FORM 4
X0306
4
2021-12-27
0
0000805928
Axogen, Inc.
AXGN
0001756302
Billet Isabelle
13631 PROGRESS BLVD.
STE. 400
ALACHUA
FL
32615
0
1
0
0
Chief Strategy and BD Officer
Common Stock
2021-12-27
4
M
0
1150
0
A
14510
D
Common Stock
2021-12-27
4
F
0
326
9.74
D
14184
D
Restricted Stock Units
0.0
2021-12-27
4
M
0
1150
0
D
2022-12-27
2022-12-27
Common Stock
2300.0
1150
D
This reflects the number of restricted stock units that vested on December 27, 2021.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of theaggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting personupon the vesting date.
/s/Isabelle Billet
2021-12-29